MedTrace Logo

Registry of Subjects at Risk of Pancreatic Cancer

NCT04095195 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-01-13

No results posted yet for this study

Summary

IRFARPC is a multicenter national registry designed to study the diagnosis and predisposing factors of subjects with an inherited increased risk for pancreatic cancer.

Conditions

  • Familial Pancreatic Cancer
  • BRCA1 Mutation
  • BRCA2 Mutation
  • Lynch Syndrome
  • FAMMM - Familial Atypical Mole Malignant Melanoma Syndrome
  • Hereditary Pancreatitis
  • Peutz-Jeghers Syndrome

Interventions

RADIATION

MRCP

Subjects fulfilling the "radiological follow-up criteria" will be submitted to MRCP or EUS according to the pancreatologist's prescription

PROCEDURE

Endoultrasonography

Subjects fulfilling the "radiological follow-up criteria" will be submitted to MRCP or EUS according to the pancreatologist's prescription

Sponsors & Collaborators

  • Associazione Italiana per lo Studio del Pancreas

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-20
Primary Completion
2044-08-20
Completion
2045-09-20

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04095195 on ClinicalTrials.gov